151 related articles for article (PubMed ID: 38025536)
1. Real-world practice of idiopathic pulmonary fibrosis: Results from a 2000-2016 cohort.
Wang YT; Shen TC; Lin CL; Tu CY; Hsia TC; Hsu WH
Open Med (Wars); 2023; 18(1):20230852. PubMed ID: 38025536
[TBL] [Abstract][Full Text] [Related]
2. The clinical impact of major comorbidities on idiopathic pulmonary fibrosis.
Suzuki A; Kondoh Y
Respir Investig; 2017 Mar; 55(2):94-103. PubMed ID: 28274539
[TBL] [Abstract][Full Text] [Related]
3. Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us?
Alfaro TM; Robalo Cordeiro C
Ther Adv Respir Dis; 2020; 14():1753466620910092. PubMed ID: 32167024
[TBL] [Abstract][Full Text] [Related]
4. Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
Oda K; Yatera K; Fujino Y; Kido T; Hanaka T; Sennari K; Fushimi K; Matsuda S; Mukae H
Respir Investig; 2018 Jan; 56(1):64-71. PubMed ID: 29325684
[TBL] [Abstract][Full Text] [Related]
5. How does comorbidity influence survival in idiopathic pulmonary fibrosis?
Hyldgaard C; Hilberg O; Bendstrup E
Respir Med; 2014 Apr; 108(4):647-53. PubMed ID: 24529739
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic pulmonary fibrosis is associated with increased impedance measures of reflux compared to non-fibrotic disease among pre-lung transplant patients.
Gavini S; Finn RT; Lo WK; Goldberg HJ; Burakoff R; Feldman N; Chan WW
Neurogastroenterol Motil; 2015 Sep; 27(9):1326-32. PubMed ID: 26176338
[TBL] [Abstract][Full Text] [Related]
7. Clusters of comorbidities in idiopathic pulmonary fibrosis.
Prior TS; Hoyer N; Hilberg O; Shaker SB; Davidsen JR; Rasmussen F; Bendstrup E
Respir Med; 2021; 185():106490. PubMed ID: 34130097
[TBL] [Abstract][Full Text] [Related]
8. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review.
Raghu G; Amatto VC; Behr J; Stowasser S
Eur Respir J; 2015 Oct; 46(4):1113-30. PubMed ID: 26424523
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Proton Pump Inhibitors in Idiopathic Pulmonary Fibrosis: A Population-Based Cohort Study.
Tran T; Assayag D; Ernst P; Suissa S
Chest; 2021 Feb; 159(2):673-682. PubMed ID: 32882251
[TBL] [Abstract][Full Text] [Related]
10. Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis.
Kärkkäinen M; Nurmi H; Kettunen HP; Selander T; Purokivi M; Kaarteenaho R
BMC Pulm Med; 2018 May; 18(1):69. PubMed ID: 29751748
[TBL] [Abstract][Full Text] [Related]
11. Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosis.
Aggarwal R; McBurney C; Schneider F; Yousem SA; Gibson KF; Lindell K; Fuhrman CR; Oddis CV
Rheumatology (Oxford); 2017 Mar; 56(3):384-389. PubMed ID: 28082622
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and comorbidities in idiopathic pulmonary fibrosis: a nationwide cohort study.
Lee JH; Park HJ; Kim S; Kim YJ; Kim HC
BMC Pulm Med; 2023 Feb; 23(1):54. PubMed ID: 36739401
[TBL] [Abstract][Full Text] [Related]
13. Left-sided heart failure burden and mortality in idiopathic pulmonary fibrosis: a population-based study.
Koteci A; Morgan AD; Portas L; Whittaker HR; Kallis C; George PM; Quint JK
BMC Pulm Med; 2022 May; 22(1):190. PubMed ID: 35549901
[TBL] [Abstract][Full Text] [Related]
14. [Idiopathic pulmonary fibrosis prognostic factors - analysis of the Czech registry].
Doubková M; Uher M; Bartoš V; Šterclová M; Lacina L; Lošťáková V; Binková I; Plačková M; Žurková M; Bittenglová R; Pšikalová J; Šišková L; Lisá P; Petřík F; Polák J; Řihák V; Skřičková J; Vašáková M
Cas Lek Cesk; 2016; 155(4):22-8. PubMed ID: 27481198
[TBL] [Abstract][Full Text] [Related]
15. A Causal Atlas on Comorbidities in Idiopathic Pulmonary Fibrosis: A Bidirectional Mendelian Randomization Study.
Zhu J; Zhou D; Wang J; Yang Y; Chen D; He F; Li Y
Chest; 2023 Aug; 164(2):429-440. PubMed ID: 36870387
[TBL] [Abstract][Full Text] [Related]
16. Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis.
Naqvi SF; Lakhani DA; Sohail AH; Maurer J; Sofka S; Sarwari A; Hadi YB
BMJ Open Respir Res; 2021 Aug; 8(1):. PubMed ID: 34376400
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic pulmonary fibrosis: Clinical behavior and aging associated comorbidities.
Buendía-Roldán I; Mejía M; Navarro C; Selman M
Respir Med; 2017 Aug; 129():46-52. PubMed ID: 28732835
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics, comorbidities, and outcomes in patients with idiopathic pulmonary fibrosis.
Alhamad EH; Cal JG; Alrajhi NN; Aharbi WM; AlRikabi AC; AlBoukai AA
Ann Thorac Med; 2020; 15(4):208-214. PubMed ID: 33381235
[TBL] [Abstract][Full Text] [Related]
19. Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis.
Yu YF; Wu N; Chuang CC; Wang R; Pan X; Benjamin NN; Devercelli G; Coultas DB
J Manag Care Spec Pharm; 2016 Apr; 22(4):414-23. PubMed ID: 27023695
[TBL] [Abstract][Full Text] [Related]
20. Utility of illness severity scores to predict mortality in patients hospitalized with respiratory deterioration of idiopathic pulmonary fibrosis.
Hyams C; Hettle D; Bibby A; Adamali HA; Barratt SL
QJM; 2021 Nov; 114(8):559-567. PubMed ID: 32609364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
